Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010.

2.50
Hdl Handle:
http://hdl.handle.net/10033/582972
Title:
Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010.
Authors:
Heideking, M; Lander, F; Hufnagel, M; Pfeifer, Y; Wicker, E; Krause, G ( 0000-0003-3328-8808 ) ; Berner, R
Abstract:
A nationwide 2-year surveillance study on invasive neonatal Escherichia coli infections in Germany was conducted. A total of 158 isolates were tested for antibiotic susceptibility. The empirical treatment regimen of ampicillin plus gentamicin for neonatal sepsis appears to remain effective, but emerging resistance needs to be closely monitored.
Affiliation:
Helmholtz Centre for infection research, Inhoffenstr. 7, D-38124 Braunschweig, Germany.
Citation:
Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010. 2013, 32 (9):1221-3 Eur. J. Clin. Microbiol. Infect. Dis.
Journal:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Issue Date:
Sep-2013
URI:
http://hdl.handle.net/10033/582972
DOI:
10.1007/s10096-013-1871-3
PubMed ID:
23558366
Type:
Article
Language:
en
ISSN:
1435-4373
Appears in Collections:
Publications of the department of epidemiology (EPID)

Full metadata record

DC FieldValue Language
dc.contributor.authorHeideking, Men
dc.contributor.authorLander, Fen
dc.contributor.authorHufnagel, Men
dc.contributor.authorPfeifer, Yen
dc.contributor.authorWicker, Een
dc.contributor.authorKrause, Gen
dc.contributor.authorBerner, Ren
dc.date.accessioned2015-11-30T15:34:58Zen
dc.date.available2015-11-30T15:34:58Zen
dc.date.issued2013-09en
dc.identifier.citationAntibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010. 2013, 32 (9):1221-3 Eur. J. Clin. Microbiol. Infect. Dis.en
dc.identifier.issn1435-4373en
dc.identifier.pmid23558366en
dc.identifier.doi10.1007/s10096-013-1871-3en
dc.identifier.urihttp://hdl.handle.net/10033/582972en
dc.description.abstractA nationwide 2-year surveillance study on invasive neonatal Escherichia coli infections in Germany was conducted. A total of 158 isolates were tested for antibiotic susceptibility. The empirical treatment regimen of ampicillin plus gentamicin for neonatal sepsis appears to remain effective, but emerging resistance needs to be closely monitored.en
dc.language.isoenen
dc.subject.meshAnti-Bacterial Agentsen
dc.subject.meshDrug Resistance, Bacterialen
dc.subject.meshEpidemiological Monitoringen
dc.subject.meshEscherichia colien
dc.subject.meshEscherichia coli Infectionsen
dc.subject.meshGermanyen
dc.subject.meshHumansen
dc.subject.meshInfant, Newbornen
dc.subject.meshMicrobial Sensitivity Testsen
dc.titleAntibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for infection research, Inhoffenstr. 7, D-38124 Braunschweig, Germany.en
dc.identifier.journalEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiologyen

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.